Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Breast Cancer ; 27(5): 1007-1016, 2020 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-32385567

RESUMO

Oncotype DX (ODX) is a multi-gene expression signature designed for estrogen receptor (ER)-positive and human epidermal growth factor receptor 2 (HER2)-negative breast cancer patients to predict the recurrence score (RS) and chemotherapy (CT) benefit. The aim of our study is to develop a prediction tool for the three RS's categories based on deep multi-layer perceptrons (DMLP) and using only the morphoimmunohistological variables. We performed a retrospective cohort of 320 patients who underwent ODX testing from three French hospitals. Clinico-pathological characteristics were recorded. We built a supervised machine learning classification model using Matlab software with 152 cases for the training and 168 cases for the testing. Three classifiers were used to learn the three risk categories of the ODX, namely the low, intermediate, and high risk. Experimental results provide the area under the curve (AUC), respectively, for the three risk categories: 0.63 [95% confidence interval: (0.5446, 0.7154), p < 0.001], 0.59 [95% confidence interval: (0.5031, 0.6769), p < 0.001], 0.75 [95% confidence interval: (0.6184, 0.8816), p < 0.001]. Concordance rate between actual RS and predicted RS ranged from 53 to 56% for each class between DMLP and ODX. The concordance rate of low and intermediate combined risk group was 85%.We developed a predictive machine learning model that could help to define patient's RS. Moreover, we integrated histopathological data and DMLP results to select tumor for ODX testing. Thus, this process allows more relevant use of histopathological data, and optimizes and enhances this information.


Assuntos
Biomarcadores Tumorais/genética , Neoplasias da Mama/genética , Modelos Genéticos , Recidiva Local de Neoplasia/epidemiologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Mama/patologia , Neoplasias da Mama/epidemiologia , Neoplasias da Mama/patologia , Neoplasias da Mama/terapia , Feminino , Seguimentos , Perfilação da Expressão Gênica , Regulação Neoplásica da Expressão Gênica , Humanos , Pessoa de Meia-Idade , Recidiva Local de Neoplasia/genética , Recidiva Local de Neoplasia/patologia , Prognóstico , Curva ROC , Receptor ErbB-2/metabolismo , Receptores de Estrogênio/metabolismo , Estudos Retrospectivos , Aprendizado de Máquina Supervisionado
2.
Ann Pathol ; 39(2): 119-129, 2019 Apr.
Artigo em Francês | MEDLINE | ID: mdl-30773224

RESUMO

Artificial Intelligence, in particular deep neural networks are the most used machine learning technics in the biomedical field. Artificial neural networks are inspired by the biological neurons; they are interconnected and follow mathematical models. Two phases are required: a learning and a using phase. The two main applications are classification and regression Computer tools such as GPU computational accelerators or some development tools such as MATLAB libraries are used. Their application field is vast and allows the management of big data in genomics and molecular biology as well as the automated analysis of histological slides. The Whole Slide Image scanner can acquire and store slides in the form of digital images. This scanning associated with deep learning algorithms allows automatic recognition of lesions through the automatic recognition of regions of interest previously validated by the pathologist. These computer aided diagnosis techniques are tested in particular in mammary pathology and dermatopathology. They will allow an efficient and a more comprehensive vision, and will provide diagnosis assistance in pathology by correlating several biomedical data such as clinical, radiological and molecular biology data.


Assuntos
Inteligência Artificial , Redes Neurais de Computação , Patologia/métodos , Previsões , Humanos , Patologia/tendências
3.
Neural Netw ; 2010 Apr 24.
Artigo em Inglês | MEDLINE | ID: mdl-20457508

RESUMO

This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...